Order Article Reprints

Cieślikowski WA, Budna-Tukan J, Świerczewska M, Ida A, Hrab M, Jankowiak A, Mazel M, Nowicki M, Milecki P, Pantel K, et al. Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer. Cancers. 2020; 12(1):160. https://doi.org/10.3390/cancers12010160

Cieślikowski, Wojciech A., Joanna Budna-Tukan, Monika Świerczewska, Agnieszka Ida, Michał Hrab, Agnieszka Jankowiak, Martine Mazel, Michał Nowicki, Piotr Milecki, Klaus Pantel, and et al. 2020. "Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer" Cancers 12, no. 1: 160. https://doi.org/10.3390/cancers12010160

Cieślikowski, W. A., Budna-Tukan, J., Świerczewska, M., Ida, A., Hrab, M., Jankowiak, A., Mazel, M., Nowicki, M., Milecki, P., Pantel, K., Alix-Panabières, C., Zabel, M., & Antczak, A. (2020). Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer. Cancers, 12(1), 160. https://doi.org/10.3390/cancers12010160